1 – 67 of 67
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis : a cohort study
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
- 2023
-
Mark
Diet and the risk of rheumatoid arthritis- a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis-results from a nested case-control study
2023) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain-a 5-year follow-up study
(
- Contribution to journal › Article
-
Mark
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
(
- Contribution to journal › Article
-
Mark
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients
2023) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
(
- Contribution to journal › Article
-
Mark
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
(
- Contribution to journal › Article
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
- 2022
-
Mark
LEVELS OF IL-6 AND OTHER INFLAMMATORY PROTEINS IN EARLY RA PREDICT JOINT DAMAGE PROGRESSION OVER 5 YEARS
(
- Contribution to journal › Published meeting abstract
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review
-
Mark
An update on polymyalgia rheumatica
(
- Contribution to journal › Scientific review
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
- 2021
-
Mark
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study
(
- Contribution to journal › Article
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
-
Mark
Proteomic data analysis for differential profiling of the autoimmune diseases SLE, RA, SS, and ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden : From infection severity to impact on care provision
(
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica : A systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
(
- Contribution to journal › Article
-
Mark
EULAR/eumusc.net standards of care for rheumatoid arthritis : cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
(
- Contribution to journal › Article
-
Mark
Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Abatacept in rheumatoid arthritis : Survival on drug, clinical outcomes, and their predictors - Data from a large national quality register
(
- Contribution to journal › Article
- 2019
-
Mark
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
(
- Contribution to journal › Scientific review
-
Mark
Lower extremity function in patients with early rheumatoid arthritis during the first five years, and relation to other disease parameters
(
- Contribution to journal › Article
-
Mark
PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
(
- Contribution to journal › Published meeting abstract
-
Mark
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
(
- Contribution to journal › Article
-
Mark
Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care
(
- Contribution to journal › Article
-
Mark
PREDICTORS OF EROSION AND JOINT SPACE NARROWING PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
The risk of clinically diagnosed gout by serum urate levels : Results from 30 years follow-up of the Malmö preventive project cohort in southern Sweden
(
- Contribution to journal › Article
-
Mark
Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden
2018) American College of Rheumatology (ACR) Annual Meeting In Arthritis & Rheumatology 70(Suppl 9).(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy : A prospective observational study of patients registered in the south Swedish SSATG registry
(
- Contribution to journal › Article
-
Mark
Large vessel involvement in biopsy-proven giant cell arteritis : incidence, distribution, and predictors
(
- Contribution to journal › Article
- 2016
-
Mark
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent : Trajectories of Disease Activity in a Large Multinational Cohort Study
(
- Contribution to journal › Article
-
Mark
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
(
- Contribution to journal › Article
-
Mark
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.
(
- Contribution to journal › Article
-
Mark
Mortality in ankylosing spondylitis: results from a nationwide population-based study.
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article
- 2015
-
Mark
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.
(
- Contribution to journal › Article
-
Mark
High Disease Activity over Time and Persistent Inflammation Are Associated with Increased Risk of Cardiovascular Disease in Patients with Early Rheumatoid Arthritis
2015) American College of Rheumatology annual meeting 2015 In Arthritis & Rheumatology 67(Suppl. 10).(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men - The MrOS study.
(
- Contribution to journal › Article
-
Mark
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis.
(
- Contribution to journal › Letter
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Reumatologisk forskning i Lund/Malmö
(
- Contribution to specialist publication or newspaper › Newspaper article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
- 2007
-
Mark
Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort
(
- Contribution to journal › Letter
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2006
-
Mark
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Increased stiffness of the abdominal aorta in women with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article